We found that CaMKKβ inhibition using STO-609 strongly reduced P-AMPK levels in human ADPKD cells, suggesting that CaMKKβ is an important upstream regulator of basal AMPK activity in cystic cells. The gene discussed is CAMKK2; the disease is autosomal dominant polycystic kidney disease.